Last reviewed · How we verify
Carcinoma in situ of adrenal cortex
Approved treatments
- Lysodren · Esteve
Lysodren works by inhibiting the production of cortisol and aldosterone in the adrenal cortex.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Carcinoma in situ of adrenal cortex patent landscape — cliff calendar, originator estates, attackable patents
- Carcinoma in situ of adrenal cortex treatment landscape brief
- Carcinoma in situ of adrenal cortex treatment updates RSS
Frequently asked questions about Carcinoma in situ of adrenal cortex
What drugs treat Carcinoma in situ of adrenal cortex?
Tracked treatments include Lysodren.
What is the treatment for Carcinoma in situ of adrenal cortex?
Standard treatment for Carcinoma in situ of adrenal cortex includes Lysodren. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Carcinoma in situ of adrenal cortex patent cliff · Carcinoma in situ of adrenal cortex CI report
- Treatment: Lysodren · Esteve
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing